NEW YORK (Reuters Health) – For acute gout flare, a 1-hour low-dose oral colchicine regimen offers comparable efficacy and better tolerability than the more common 6-hour high-dose regimen,…
NEW YORK (Reuters Health) – In patients with peptic ulcers, eradication of Helicobacter pylori seemed to double the risk of new-onset reflux – but only in cohort study…
NEW YORK (Reuters Health) – Although inhaled corticosteroids (ICS) can help prevent exacerbations of chronic obstructive pulmonary disease (COPD), an analysis of randomized trials suggests that the benefits…
NEW YORK (Reuters Health) – Endovascular surgery on the descending thoracic aorta offers many advantages over open surgery, including fewer complications, a reduced risk of early mortality and…
NEW YORK (Reuters Health) – For patients with diabetes and complex multivessel coronary artery disease, the risk of repeat vascularization within one year is elevated 3-fold after percutaneous…
NEW YORK (Reuters Health) – The presence of deep venous thrombosis (DVT) in patients with pulmonary embolism is associated with an increased risk of death, according to a…
NEW YORK (Reuters Health) – Long-term treatment with clofazimine or nitroimidazoles may help control Crohn’s disease, according to the authors of a systematic review and meta-analysis. Several bacteria…
NEW YORK (Reuters Health) – In women over 55, simple ovarian cysts are common, usually resolving or persisting without progression, according to data from the prospective Prostate, Lung,…
NEW YORK (Reuters Health) – A single negative whole-leg compression ultrasound (CUS) can effectively rule out deep vein thrombosis (DVT) in many patients, according to a meta-analysis in…
NEW YORK (Reuters Health) – In patients with schizophrenia, clozapine does not seem to increase the risk of cardiovascular death relative to risperidone, despite known differences in cardiometabolic…